GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acrux Ltd (FRA:FJY) » Definitions » Short-Term Debt

Acrux (FRA:FJY) Short-Term Debt : €0.92 Mil (As of Jun. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Acrux Short-Term Debt?

Acrux's Short-Term Debt for the quarter that ended in Jun. 2024 was €0.92 Mil.

Acrux's quarterly Short-Term Debt increased from Jun. 2023 (€0.00 Mil) to Dec. 2023 (€0.19 Mil) and increased from Dec. 2023 (€0.19 Mil) to Jun. 2024 (€0.92 Mil).

Acrux's annual Short-Term Debt stayed the same from Jun. 2022 (€0.00 Mil) to Jun. 2023 (€0.00 Mil) but then increased from Jun. 2023 (€0.00 Mil) to Jun. 2024 (€0.92 Mil).


Acrux Short-Term Debt Historical Data

The historical data trend for Acrux's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acrux Short-Term Debt Chart

Acrux Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.92

Acrux Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.14 - 0.19 0.92

Acrux Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


Acrux Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Acrux's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Acrux Business Description

Traded in Other Exchanges
Address
103-113 Stanley Street, West Melbourne, Melbourne, VIC, AUS, 3003
Acrux Ltd is a pharmaceutical company dedicated to developing and commercializing generic transdermal and topical prescription pharmaceuticals. The group is formulating and developing a range of topical generic products by leveraging its skilled workforce, on-site laboratories, GMP manufacturing suite, and technical, clinical, and commercial experience to bring affordable products to market. Geographically, it has a presence in Australia; the United States; Europe, and other countries. The firm operates in a single segment and derives revenue from developing and commercializing pharmaceutical products that administer drugs topically. Its product pipeline products include Lenzetto, Evamist, Testosterone Topical Solution, and among others.

Acrux Headlines

No Headlines